The safety of in-hospital initiation of SGLT2 inhibitor with MRA therapy in patients hospitalized for heart failure with a reduced left ventricular ejection fraction and chronic kidney disease

被引：0
|
作者：
Obertynska, O. [1 ]
Rasputina, L. [1 ]
机构：
[1] Natl Pirogov Mem Med Univ, Vinnitsa, Ukraine
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.1055
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cardiac remodeling with SGLT2 inhibitors in heart failure with reduced ejection fraction
    Romeo, Francisco J.
    Del Buono, Marco G.
    Aguilar-gallardo, Jose S.
    Lorente-ros, Marta
    Damonte, Juan I.
    Chiabrando, Juan G.
    Dixon, Dave L.
    Biondi-zoccai, Giuseppe
    Abbate, Antonio
    Carbone, Salvatore
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2024, 72 (01) : 95 - 97
  • [22] EFFECT OF SGLT2 INHIBITORS ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Usman, Muhammad Shariq
    Siddiqi, Tariq Jamal
    Coats, Andrew
    Rosano, Giuseppe
    Filippatos, Gerasimos
    Anker, Stefan D.
    Butler, Javed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 346 - 346
  • [23] Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction
    Starr, Jessica A.
    Pinner, Nathan A.
    Lisenby, Katelin M.
    Osmonson, Alyssa
    PHARMACOTHERAPY, 2021, 41 (06): : 526 - 536
  • [24] SGLT2 INHIBITOR PRESCRIPTION RATE FOR PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)
    Kim, Justin
    Chakrala, Teja
    Prakash, Roshni
    Ghaffar, Umar
    Patel, Jaymin
    Dass, Bhagwan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 404 - 404
  • [25] The risks and benefits of spironolactone use in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease
    Obertynska, O.
    EUROPEAN HEART JOURNAL, 2021, 42 : 895 - 895
  • [26] Incidence and potential predictors of SGLT2 inhibitor initiation in acutely hospitalized patients with heart failure
    Lanier, Cameron
    Brumit, Jessica C.
    Tharp, Jennifer
    Crawford, Jacquelyn
    White, Kathleen M.
    Wilson, Vera
    Covert, Kelly
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025,
  • [27] Follow the EMPULSE: In-hospital initiation of empagliflozin for heart failure across the spectrum of left ventricular ejection fraction
    Lien, Tann
    Srikanth, Kishan
    Ambrosy, Andrew P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 971 - 973
  • [28] MARKERS OF SYMPTOMATIC HEART FAILURE IN CHRONIC KIDNEY DISEASE PATIENTS WITH NORMAL LEFT VENTRICULAR EJECTION FRACTION
    Zilisteanu, Diana-Silvia
    Rusu, Elena-Emanuela
    Atasie, Teodora
    Rosca, Monica
    Calin, Andreea
    Tanase, Cristiana
    Voiculescu, Mihai
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [29] Increased Left Ventricular Ejection Fraction In Patients With Heart Failure With Reduced Ejection Fraction On Baroreflex Activation Therapy
    Pham, Vu
    Gan, Arnold
    Fong, Michael
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [30] In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States
    Greene, Stephen J.
    Triana, Taylor S.
    Ionescu-Ittu, Raluca
    Burne, Rebecca M.
    Guerin, Annie
    Borentain, Maria
    Kessler, Paul D.
    Tugcu, Aylin
    DeSouza, Mary M.
    Felker, G. Michael
    Chen, Lei
    JACC-HEART FAILURE, 2020, 8 (11) : 943 - 953
12345